Covering: 2000 to January 2023 Diabetes is a metabolic disease of serious concern
nowadays, with a negative economic impact. In 2021, the International Diabetes Federation …

Bioactive peptides with high potency against numerous human disorders have been
regarded as a promising therapy in disease control. These peptides could be released from …

Abstract Peptidyl arginine deiminase 4 (PAD4) is an important biocatalytic enzymes involved
in the conversion of protein arginine to citrulline, its dysregulation has a great impact on …

A thin-layer chromatography (TLC)-bioautographic method was developed with the aim to
detect dipeptidyl peptidase IV (DPP IV) inhibitors from plant extracts. The basic principle of …

Early detection and effective treatment of thyroid cancer are vital due to the aggressiveness
and high mortality rate of the cancer. Nevertheless, the exploration of dipeptidyl peptidase-IV …

Abstract Dipeptidyl peptidase 4 (DPP-4) inhibitors are used for the treatment of type-2
diabetes mellitus. Various synthetic inhibitors have been developed to date, and plants …

Background: Pharmacologic treatments for type 2 diabetes are based upon increasing
insulin availability and improving sensitivity to insulin. Nowadays, glucagon like peptide-1 …

Evogliptin is a newly developed dipeptidyl peptidase-4 (DPP-4) inhibitor, which is expected
to be combined with metformin for treating type 2 diabetes mellitus. We investigated the …

This article presents a new label-free fluorescence assay based on supramolecular self-
assembly of cucurbit [7] uril and specific peptide Gly-Pro-Phe-Gly for monitoring DPP4 …

In this study, an ultrahigh performance liquid chromatography and tandem mass
spectrometry (UPLC-MS/MS) method was developed for the detection of aldose reductase …